semaglutide canada patent expiry Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo's Ozempic Patent Expires Jan.

Glucose Control's evidence rests largely on a single proof-of-concept 2020 clinical trial published in BMJ Open Diabetes Research & Care

However, these mechanisms are complex, and more research is needed before GLP-3 treatments become standard care

Key insights from these studies include: * Fruiting bodies of gourmet wild and cultivated mushrooms, such as Hen of the Woods, Shiitake, King Boletes, Enokitake, and Oyster Mushroom species, exhibited ergothioneine levels 500x to 1000x higher than those found in grains and vegetables

The consumer was prohibited from suing the manufacturer because the consumer didnt have a contract with the manufacturer

Personalized Dosage Adjustments We start each patient on a low dose of semaglutide GLP-1 and gradually increase it to maximize effectiveness while minimizing side effects